ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)
CUSIP: 00166B105
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 132,496,020
- Total 13F shares
- 27,785,299
- Share change
- -1,286,146
- Total reported value
- $51,273,440
- Put/Call ratio
- 0%
- Price per share
- $1.83
- Number of holders
- 60
- Value change
- +$2,395,861
- Number of buys
- 16
- Number of sells
- 38
Quarterly Holders Quick Answers
What is CUSIP 00166B105?
CUSIP 00166B105 identifies ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00166B105:
Top shareholders of ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| LSV Associates, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,526,963
|
$61,575,751 | — | 13 Dec 2021 | |
| venBio Partners LLC |
13F
|
Company |
7.3%
|
9,699,925
|
$4,026,439 | — | 30 Jun 2025 | |
| HBM Healthcare Investments (Cayman) Ltd. |
13D/G
|
— |
8.4%
|
4,500,000
|
$2,295,000 | +$547,266 | 31 Mar 2025 | |
| Redmile Group, LLC |
13D/G
13F
|
Company |
8.5%
|
4,641,455
|
$2,042,240 | $0 | 30 Jun 2025 | |
| TANG CAPITAL PARTNERS LP |
13D/G
|
TANG CAPITAL MANAGEMENT, LLC |
6.3%
|
3,296,883
|
$1,681,410 | $0 | 31 Dec 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.4%
|
3,158,265
|
$1,310,996 | — | 30 Jun 2025 | |
| Almitas Capital LLC |
13F
|
Company |
1.9%
|
2,538,355
|
$1,053,671 | — | 30 Jun 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
3.4%
|
1,798,875
|
$917,426 | $0 | 29 Nov 2024 | |
| Sophia Randolph |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
mixed-class rows
|
420,711
mixed-class rows
|
$840,334 | — | 14 Aug 2024 | |
| Jaume Pons |
3/4/5
|
PRESIDENT & CSO |
—
mixed-class rows
|
773,821
mixed-class rows
|
$666,412 | — | 19 Feb 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
1,600,808
|
$664,336 | — | 30 Jun 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.96%
|
1,267,999
|
$525,000 | — | 30 Jun 2025 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.03%
|
41,000
|
$508,000 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.78%
|
1,035,127
|
$429,578 | — | 30 Jun 2025 | |
| Peter S. Garcia |
3/4/5
|
CHIEF FINANCIAL OFFICER |
—
mixed-class rows
|
201,516
mixed-class rows
|
$313,511 | — | 14 Aug 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.54%
|
716,297
|
$297,335 | — | 30 Jun 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.53%
|
703,300
|
$291,940 | — | 30 Jun 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.5%
|
668,747
|
$277,597 | — | 30 Jun 2025 | |
| Privium Fund Management B.V. |
13F
|
Company |
0.38%
|
509,059
|
$220,575 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.37%
|
492,614
|
$204,484 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.36%
|
477,934
|
$198,390 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
315,421
|
$130,984 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.22%
|
289,693
|
$120,252 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.22%
|
288,685
|
$119,805 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.15%
|
203,266
|
$84,376 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.12%
|
163,813
|
$67,999 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.1%
|
135,909
|
$56,416 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
133,433
|
$55,388 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
124,232
|
$51,569 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.09%
|
117,465
|
$48,759 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.08%
|
106,280
|
$44,638 | — | 30 Jun 2025 | |
| BANK OF NOVA SCOTIA |
13F
|
Company |
0.08%
|
105,858
|
$43,942 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.07%
|
88,352
|
$36,675 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.06%
|
85,399
|
$35,449 | — | 30 Jun 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.06%
|
81,326
|
$34,000 | — | 30 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.06%
|
74,770
|
$31,037 | — | 30 Jun 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
58,307
|
$24,203 | — | 30 Jun 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.03%
|
45,583
|
$18,921 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.03%
|
44,133
|
$18,320 | — | 30 Jun 2025 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.03%
|
39,279
|
$18,072 | — | 30 Jun 2025 | |
| NAN FUNG TRINITY (HK) Ltd |
13F
|
Company |
0.03%
|
41,950
|
$17,413 | — | 30 Jun 2025 | |
| Point72 Asia (Singapore) Pte. Ltd. |
13F
|
Company |
0.02%
|
27,709
|
$11,502 | — | 30 Jun 2025 | |
| HC Advisors, LLC |
13F
|
Company |
0.02%
|
20,500
|
$8,510 | — | 30 Jun 2025 | |
| Callan Family Office, LLC |
13F
|
Company |
0.01%
|
19,778
|
$8,210 | — | 30 Jun 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.01%
|
19,292
|
$8,000 | — | 30 Jun 2025 | |
| JSF Financial, LLC |
13F
|
Company |
0.01%
|
17,500
|
$7,264 | — | 30 Jun 2025 | |
| Abel Hall, LLC |
13F
|
Company |
0.01%
|
15,209
|
$6,313 | — | 30 Jun 2025 | |
| MONETA GROUP INVESTMENT ADVISORS LLC |
13F
|
Company |
0.01%
|
15,196
|
$6,308 | — | 30 Jun 2025 | |
| Lido Advisors, LLC |
13F
|
Company |
0.01%
|
13,220
|
$5,488 | — | 30 Jun 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.01%
|
12,306
|
$5,050 | — | 30 Jun 2025 |
Institutional Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q3 2025
As of 30 Sep 2025,
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,785,299 shares.
The largest 10 holders included
venBio Partners LLC, Redmile Group, LLC, MILLENNIUM MANAGEMENT LLC, Almitas Capital LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, Driehaus Capital Management LLC, TWO SIGMA ADVISERS, LP, AMERIPRISE FINANCIAL INC, and TWO SIGMA INVESTMENTS, LP.
This page lists
60
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
58
Q3 2025 holders
60
Holder diff
2
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.